GHK-Cu (Copper Tripeptide-1) is one of the most extensively researched peptides in tissue repair — stimulating collagen, recruiting stem cells, promoting angiogenesis, and modulating the inflammatory cascade to achieve organized regeneration over fibrotic scarring.
GHK-Cu works through four converging mechanisms that address every phase of wound repair — hemostasis, inflammation, proliferation, and remodeling.
GHK-Cu is one of the most potent known stimulators of collagen synthesis, particularly types I and III. It simultaneously upregulates decorin, glycosaminoglycans (GAGs), versican, and biglycan while modulating matrix metalloproteinases (MMPs) to enable controlled ECM remodeling rather than disorganized fibrotic deposition. This dual role — building new ECM while preventing scarring — is central to its wound-healing effects.[3][6]
New blood vessel formation is rate-limiting in wound healing — without adequate oxygen and nutrient delivery, tissue cannot regenerate. GHK-Cu upregulates vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), directly stimulating endothelial proliferation and capillary sprouting. It also promotes nerve growth factor (NGF), contributing to neurovascular remodeling in the wound bed.[5][8]
GHK-Cu acts as a chemoattractant for mesenchymal stem cells (MSCs) and endothelial progenitor cells, drawing regenerative cells to the wound site. It also upregulates Wnt pathway components associated with stem cell self-renewal, promoting regenerative rather than merely reparative healing responses. This distinguishes it from simpler wound-healing agents that only address one phase of repair.[4][9]
Excessive or prolonged inflammation is the primary driver of fibrotic scarring. GHK-Cu suppresses TNF-α, IL-6, and the pro-fibrotic arm of TGF-β₁ signaling, shifting wound resolution toward an anti-inflammatory, remodeling phenotype. Simultaneously, it upregulates superoxide dismutase (SOD) and ferritin to neutralize the oxidative burst associated with wound inflammation, protecting newly formed tissue from free radical damage.[6][7]
Despite stimulating collagen production, GHK-Cu paradoxically prevents pathological fibrosis. It reduces myofibroblast activation — the primary cellular driver of hypertrophic scarring — and upregulates decorin, a small proteoglycan that directly antagonizes TGF-β₁. This makes GHK-Cu particularly useful in wounds prone to keloid or hypertrophic scar formation, where reducing myofibroblast persistence is the primary therapeutic goal.[6][7]
Copper is an essential cofactor for lysyl oxidase, the enzyme responsible for crosslinking collagen and elastin fibers — a critical step in wound tensile strength recovery. GHK serves as a high-affinity bioavailable copper shuttle, concentrating Cu²⁺ at wound sites where lysyl oxidase activity is needed, without the toxicity risks of inorganic copper supplementation. It also activates copper-dependent cytochrome c oxidase, supporting mitochondrial energy production in regenerating cells.[1][3]
Peer-reviewed research from in vitro, in vivo, and clinical studies demonstrating GHK-Cu's wound-healing effects.
| Study / Authors | Year | Type | Key Finding | PMID |
|---|---|---|---|---|
| Canapp et al. — Effect of topical GHK-Cu on healing of open wounds | 2003 | In Vivo | Topical GHK-Cu significantly accelerated wound closure and epithelialization in canine wound models vs. saline controls | 14535425 |
| Kang et al. — Self-assembled GHK-Cu nanoparticles for wound healing | 2018 | In Vivo | GHK-Cu nanoparticle formulation accelerated wound closure, increased collagen deposition, and enhanced angiogenesis in murine models | 29228788 |
| Siméon et al. — Expression of GAGs and proteoglycans in wounds: effects of GHK-Cu | 2000 | In Vivo | GHK-Cu increased decorin, versican, and biglycan expression in wound tissue, contributing to organized ECM remodeling | 10759380 |
| Siméon et al. — Myofibroblasts and wound contraction: effects of GHK-Cu | 1999 | In Vivo | GHK-Cu modulated TGF-β and myofibroblast activity, promoting organized contraction over fibrosis | 10411645 |
| Maquart et al. — Stimulation of collagen synthesis by GHK-Cu tripeptide | 1999 | In Vitro | Dose-dependent stimulation of collagen types I, III, and V, along with GAG synthesis in dermal fibroblast cultures | 10188757 |
| Pickart & Margolina — Regenerative and protective actions of GHK-Cu | 2018 | Review | Comprehensive review integrating genomic data with wound-healing evidence; positioned GHK-Cu as a broad-spectrum restorative molecule | 29443350 |
Topical application has the strongest evidence base for wound healing. Injectable use is preclinical/investigational.
For full reconstitution and injectable dosing details, see the complete dosing protocol guide.
GHK-Cu is sold as a research compound and cosmetic ingredient. Injectable forms are not approved by the FDA or any regulatory agency for human therapeutic use. The information on this page is compiled from published peer-reviewed research and is intended for educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any health decisions.